Table 1.
Characteristic | Patients (N = 77) |
---|---|
Median age, years (range) | 62 (25 to 89) |
Sex, n (%) | |
Female | 51 (66) |
Male | 26 (34) |
Ethnicity, n (%) | |
White | 66 (85) |
Black | 6 (8) |
American Indian | 1 (1) |
Asian | 4 (6) |
Median height, cm (range) | 167.0 (152.0 to 197.0) |
Median weight, kg (range) | 68.2 (42.0 to 119.0) |
ECOG PS, n (%) | |
0 | 50 (65) |
1 | 27 (35) |
Tumor type, n (%) | |
Endometrium/uterus | 12 (16) |
Prostate | 10 (13) |
Ovary | 9 (12) |
Colon/rectum | 9 (12) |
Breast | 6 (8) |
Neuroendocrine | 4 (5) |
Head and neck | 4 (5) |
Other | 23 (29) |
Prior treatment regimens, n (%) | |
Chemotherapy | 69 (90) |
Biologic therapy (monoclonal antibodies) | 39 (51) |
Hormonal therapy | 20 (26) |
Immunotherapy | 4 (5) |
No. of prior chemotherapy regimens, n (%) | |
1 | 12 (16) |
2 | 15 (19) |
3 | 12 (16) |
4 | 9 (12) |
>4 | 21 (27) |
Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status.